ID   NGLY1_HUMAN             Reviewed;         654 AA.
AC   Q96IV0; B4DJE9; Q59FB1; Q6PJD8; Q9BVR8; Q9NR70;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 131.
DE   RecName: Full=Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase;
DE            Short=PNGase;
DE            Short=hPNGase;
DE            EC=3.5.1.52;
DE   AltName: Full=N-glycanase 1;
DE   AltName: Full=Peptide:N-glycanase;
GN   Name=NGLY1; Synonyms=PNG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10831608; DOI=10.1083/jcb.149.5.1039;
RA   Suzuki T., Park H., Hollingsworth N.M., Sternglanz R., Lennarz W.J.;
RT   "PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase.";
RL   J. Cell Biol. 149:1039-1052(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-654 (ISOFORM 2).
RC   TISSUE=Lymph, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH VCP.
RX   PubMed=15362974; DOI=10.1042/BJ20041498;
RA   McNeill H., Knebel A., Arthur J.S., Cuenda A., Cohen P.;
RT   "A novel UBA and UBX domain protein that binds polyubiquitin and VCP
RT   and is a substrate for SAPKs.";
RL   Biochem. J. 384:391-400(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=14749736; DOI=10.1038/sj.emboj.7600090;
RA   Blom D., Hirsch C., Stern P., Tortorella D., Ploegh H.L.;
RT   "A glycosylated type I membrane protein becomes cytosolic when
RT   peptide: N-glycanase is compromised.";
RL   EMBO J. 23:650-658(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RAD23B AND PSMC1.
RX   PubMed=15358861; DOI=10.1073/pnas.0405663101;
RA   Katiyar S., Li G., Lennarz W.J.;
RT   "A complex between peptide:N-glycanase and two proteasome-linked
RT   proteins suggests a mechanism for the degradation of misfolded
RT   glycoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13774-13779(2004).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=15610852; DOI=10.1016/j.chembiol.2004.11.010;
RA   Misaghi S., Pacold M.E., Blom D., Ploegh H.L., Korbel G.A.;
RT   "Using a small molecule inhibitor of peptide: N-glycanase to probe its
RT   role in glycoprotein turnover.";
RL   Chem. Biol. 11:1677-1687(2004).
RN   [10]
RP   INTERACTION WITH DERL1.
RX   PubMed=16055502; DOI=10.1091/mbc.E05-04-0345;
RA   Katiyar S., Joshi S., Lennarz W.J.;
RT   "The retrotranslocation protein derlin-1 binds peptide:N-glycanase to
RT   the endoplasmic reticulum.";
RL   Mol. Biol. Cell 16:4584-4594(2005).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   INVOLVEMENT IN CDDG.
RX   PubMed=22581936; DOI=10.1136/jmedgenet-2012-100819;
RA   Need A.C., Shashi V., Hitomi Y., Schoch K., Shianna K.V.,
RA   McDonald M.T., Meisler M.H., Goldstein D.B.;
RT   "Clinical application of exome sequencing in undiagnosed genetic
RT   conditions.";
RL   J. Med. Genet. 49:353-361(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-137, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   INVOLVEMENT IN CDDG.
RX   PubMed=24651605; DOI=10.1038/gim.2014.22;
RA   Enns G.M., Shashi V., Bainbridge M., Gambello M.J., Zahir F.R.,
RA   Bast T., Crimian R., Schoch K., Platt J., Cox R., Bernstein J.A.,
RA   Scavina M., Walter R.S., Bibb A., Jones M., Hegde M., Graham B.H.,
RA   Need A.C., Oviedo A., Schaaf C.P., Boyle S., Butte A.J., Chen R.,
RA   Clark M.J., Haraksingh R., Cowan T.M., He P., Langlois S.,
RA   Zoghbi H.Y., Snyder M., Gibbs R.A., Freeze H.H., Goldstein D.B.;
RT   "Mutations in NGLY1 cause an inherited disorder of the endoplasmic
RT   reticulum-associated degradation pathway.";
RL   Genet. Med. 16:751-758(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 11-109 IN COMPLEX WITH VCP,
RP   AND DOMAIN.
RX   PubMed=16807242; DOI=10.1074/jbc.M601173200;
RA   Allen M.D., Buchberger A., Bycroft M.;
RT   "The PUB domain functions as a p97 binding module in human peptide N-
RT   glycanase.";
RL   J. Biol. Chem. 281:25502-25508(2006).
CC   -!- FUNCTION: Specifically deglycosylates the denatured form of N-
CC       linked glycoproteins in the cytoplasm and assists their
CC       proteasome-mediated degradation. Cleaves the beta-aspartyl-
CC       glucosamine (GlcNAc) of the glycan and the amide side chain of
CC       Asn, converting Asn to Asp. Prefers proteins containing high-
CC       mannose over those bearing complex type oligosaccharides. Can
CC       recognize misfolded proteins in the endoplasmic reticulum that are
CC       exported to the cytosol to be destroyed and deglycosylate them,
CC       while it has no activity toward native proteins. Deglycosylation
CC       is a prerequisite for subsequent proteasome-mediated degradation
CC       of some, but not all, misfolded glycoproteins.
CC       {ECO:0000269|PubMed:14749736, ECO:0000269|PubMed:15358861}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(4)-(acetyl-beta-D-
CC       glucosaminyl)asparagine residue in which the glucosamine residue
CC       may be further glycosylated, to yield a (substituted) N-acetyl-
CC       beta-D-glucosaminylamine and a peptide containing an aspartate
CC       residue.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by Z-VAD-fmk, a well-known caspase
CC       inhibitor, which inhibits enzyme activity through covalent binding
CC       of the carbohydrate to the single Cys-306 residue.
CC       {ECO:0000269|PubMed:15610852}.
CC   -!- SUBUNIT: Component of a complex required to couple
CC       retrotranslocation, ubiquitination and deglycosylation composed of
CC       NGLY1, SAKS1, AMFR, VCP and RAD23B. Interacts with the proteasome
CC       components RAD23B and PSMC1. Interacts with directly with VCP.
CC       Interacts with DERL1, bringing it close to the endoplasmic
CC       reticulum membrane. Interacts with SAKS1.
CC       {ECO:0000269|PubMed:15358861, ECO:0000269|PubMed:15362974,
CC       ECO:0000269|PubMed:16055502, ECO:0000269|PubMed:16807242}.
CC   -!- INTERACTION:
CC       Q96NT3:GUCD1; NbExp=3; IntAct=EBI-6165879, EBI-8293751;
CC       Q99743:NPAS2; NbExp=4; IntAct=EBI-6165879, EBI-3932727;
CC       P54725:RAD23A; NbExp=7; IntAct=EBI-6165879, EBI-746453;
CC       P54727:RAD23B; NbExp=7; IntAct=EBI-6165879, EBI-954531;
CC       O14545:TRAFD1; NbExp=5; IntAct=EBI-6165879, EBI-1396921;
CC       Q9BYV2:TRIM54; NbExp=5; IntAct=EBI-6165879, EBI-2130429;
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-6165879, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-6165879, EBI-10173939;
CC       Q14CS0:UBXN2B; NbExp=5; IntAct=EBI-6165879, EBI-1993619;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15358861}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q96IV0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96IV0-2; Sequence=VSP_020344;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q96IV0-3; Sequence=VSP_020345, VSP_020346;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q96IV0-4; Sequence=VSP_020343;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q96IV0-5; Sequence=VSP_043501;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The PUB domain mediates the interaction with VCP.
CC       {ECO:0000269|PubMed:16807242}.
CC   -!- DISEASE: Congenital disorder of deglycosylation (CDDG)
CC       [MIM:615273]: A multisystem disorder characterized by
CC       developmental delay, hypotonia, abnormal involuntary movements and
CC       alacrima or poor tear production. Other features include
CC       microcephaly, intractable seizures, abnormal eye movements and
CC       evidence of liver dysfunction, probably due to cytoplasmic
CC       accumulation of storage material in vacuoles.
CC       {ECO:0000269|PubMed:22581936, ECO:0000269|PubMed:24651605}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: In case of infection by cytomegaloviruses, it is
CC       not essential for degradation of MHC class I heavy chains.
CC   -!- SIMILARITY: Belongs to the transglutaminase-like superfamily.
CC       PNGase family. {ECO:0000255|PROSITE-ProRule:PRU00731}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17220.1; Type=Erroneous termination; Positions=77; Note=Translated as Glu.; Evidence={ECO:0000305};
CC       Sequence=BAD92786.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF250924; AAF74720.2; -; mRNA.
DR   EMBL; AK296047; BAG58811.1; -; mRNA.
DR   EMBL; AB209549; BAD92786.1; ALT_INIT; mRNA.
DR   EMBL; AC092798; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000963; AAH00963.1; -; mRNA.
DR   EMBL; BC007226; AAH07226.1; -; mRNA.
DR   EMBL; BC017220; AAH17220.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS33719.1; -. [Q96IV0-1]
DR   CCDS; CCDS46777.1; -. [Q96IV0-5]
DR   CCDS; CCDS46778.1; -. [Q96IV0-2]
DR   CCDS; CCDS46779.1; -. [Q96IV0-3]
DR   RefSeq; NP_001138765.1; NM_001145293.1. [Q96IV0-2]
DR   RefSeq; NP_001138766.1; NM_001145294.1. [Q96IV0-5]
DR   RefSeq; NP_001138767.1; NM_001145295.1. [Q96IV0-3]
DR   RefSeq; NP_060767.2; NM_018297.3. [Q96IV0-1]
DR   UniGene; Hs.368960; -.
DR   PDB; 2CCQ; X-ray; 1.60 A; A=11-109.
DR   PDB; 2CM0; X-ray; 1.90 A; A=11-109.
DR   PDBsum; 2CCQ; -.
DR   PDBsum; 2CM0; -.
DR   ProteinModelPortal; Q96IV0; -.
DR   SMR; Q96IV0; -.
DR   BioGrid; 120885; 20.
DR   IntAct; Q96IV0; 17.
DR   MINT; MINT-3054125; -.
DR   STRING; 9606.ENSP00000280700; -.
DR   iPTMnet; Q96IV0; -.
DR   PhosphoSitePlus; Q96IV0; -.
DR   BioMuta; NGLY1; -.
DR   DMDM; 74732105; -.
DR   EPD; Q96IV0; -.
DR   MaxQB; Q96IV0; -.
DR   PaxDb; Q96IV0; -.
DR   PeptideAtlas; Q96IV0; -.
DR   PRIDE; Q96IV0; -.
DR   DNASU; 55768; -.
DR   Ensembl; ENST00000280700; ENSP00000280700; ENSG00000151092. [Q96IV0-1]
DR   Ensembl; ENST00000396649; ENSP00000379886; ENSG00000151092. [Q96IV0-3]
DR   Ensembl; ENST00000417874; ENSP00000389888; ENSG00000151092. [Q96IV0-5]
DR   Ensembl; ENST00000428257; ENSP00000387430; ENSG00000151092. [Q96IV0-2]
DR   GeneID; 55768; -.
DR   KEGG; hsa:55768; -.
DR   UCSC; uc003cdl.4; human. [Q96IV0-1]
DR   CTD; 55768; -.
DR   DisGeNET; 55768; -.
DR   GeneCards; NGLY1; -.
DR   HGNC; HGNC:17646; NGLY1.
DR   HPA; HPA036825; -.
DR   MalaCards; NGLY1; -.
DR   MIM; 610661; gene.
DR   MIM; 615273; phenotype.
DR   neXtProt; NX_Q96IV0; -.
DR   OpenTargets; ENSG00000151092; -.
DR   Orphanet; 404454; Alacrimia-choreoathetosis-liver dysfunction syndrome.
DR   PharmGKB; PA38462; -.
DR   eggNOG; KOG0909; Eukaryota.
DR   eggNOG; ENOG410XP69; LUCA.
DR   GeneTree; ENSGT00390000006540; -.
DR   HOGENOM; HOG000247069; -.
DR   HOVERGEN; HBG082026; -.
DR   InParanoid; Q96IV0; -.
DR   KO; K01456; -.
DR   OMA; DVAWQHT; -.
DR   OrthoDB; EOG091G09YB; -.
DR   PhylomeDB; Q96IV0; -.
DR   TreeFam; TF315254; -.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   ChiTaRS; NGLY1; human.
DR   EvolutionaryTrace; Q96IV0; -.
DR   GeneWiki; NGLY1; -.
DR   GenomeRNAi; 55768; -.
DR   PRO; PR:Q96IV0; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000151092; -.
DR   CleanEx; HS_NGLY1; -.
DR   ExpressionAtlas; Q96IV0; baseline and differential.
DR   Genevisible; Q96IV0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000224; F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; IBA:GO_Central.
DR   GO; GO:0006516; P:glycoprotein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006515; P:misfolded or incompletely synthesized protein catabolic process; IBA:GO_Central.
DR   GO; GO:0006517; P:protein deglycosylation; IBA:GO_Central.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR006588; Peptide_N_glycanase_PAW_dom.
DR   InterPro; IPR018997; PUB_domain.
DR   InterPro; IPR002931; Transglutaminase-like.
DR   Pfam; PF04721; PAW; 1.
DR   Pfam; PF09409; PUB; 1.
DR   Pfam; PF01841; Transglut_core; 1.
DR   SMART; SM00613; PAW; 1.
DR   SMART; SM00580; PUG; 1.
DR   SMART; SM00460; TGc; 1.
DR   SUPFAM; SSF143503; SSF143503; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   PROSITE; PS51398; PAW; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Hydrolase; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    654       Peptide-N(4)-(N-acetyl-beta-
FT                                glucosaminyl)asparagine amidase.
FT                                /FTId=PRO_0000248971.
FT   DOMAIN       30     91       PUB.
FT   DOMAIN      454    654       PAW. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00731}.
FT   ACT_SITE    309    309       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    336    336       {ECO:0000250}.
FT   ACT_SITE    353    353       {ECO:0000250}.
FT   METAL       250    250       Zinc. {ECO:0000250}.
FT   METAL       253    253       Zinc. {ECO:0000250}.
FT   METAL       283    283       Zinc. {ECO:0000250}.
FT   METAL       286    286       Zinc. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     137    137       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    523       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_020343.
FT   VAR_SEQ       1     43       MAAAALGSSSGSASPAVAELCQNTPETFLEASKLLLTYADN
FT                                IL -> M (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043501.
FT   VAR_SEQ     335    383       DHVWTEVYSPSQQRWLHCDACEDVCDKPLLYEIGWGKKLSY
FT                                VIAFSKDE -> ELQRTLSLKLTTLKEIGKTFLRISKRQKL
FT                                IQ (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020344.
FT   VAR_SEQ     538    558       VYLARKEGSSFAYISWKFECG -> ITVFTPMLIFLVPLKL
FT                                FWKQN (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020345.
FT   VAR_SEQ     559    654       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_020346.
FT   VARIANT     581    581       V -> I (in dbSNP:rs7621398).
FT                                /FTId=VAR_027385.
FT   VARIANT     591    591       Q -> R (in dbSNP:rs7635089).
FT                                /FTId=VAR_027386.
FT   HELIX        15     20       {ECO:0000244|PDB:2CCQ}.
FT   HELIX        25     44       {ECO:0000244|PDB:2CCQ}.
FT   HELIX        49     52       {ECO:0000244|PDB:2CCQ}.
FT   STRAND       53     55       {ECO:0000244|PDB:2CCQ}.
FT   HELIX        59     64       {ECO:0000244|PDB:2CCQ}.
FT   TURN         65     67       {ECO:0000244|PDB:2CCQ}.
FT   HELIX        71     78       {ECO:0000244|PDB:2CCQ}.
FT   STRAND       84     88       {ECO:0000244|PDB:2CCQ}.
FT   HELIX        95    106       {ECO:0000244|PDB:2CCQ}.
SQ   SEQUENCE   654 AA;  74390 MW;  94BD44316EA66AF6 CRC64;
     MAAAALGSSS GSASPAVAEL CQNTPETFLE ASKLLLTYAD NILRNPNDEK YRSIRIGNTA
     FSTRLLPVRG AVECLFEMGF EEGETHLIFP KKASVEQLQK IRDLIAIERS SRLDGSNKSH
     KVKSSQQPAA STQLPTTPSS NPSGLNQHTR NRQGQSSDPP SASTVAADSA ILEVLQSNIQ
     HVLVYENPAL QEKALACIPV QELKRKSQEK LSRARKLDKG INISDEDFLL LELLHWFKEE
     FFHWVNNVLC SKCGGQTRSR DRSLLPSDDE LKWGAKEVED HYCDACQFSN RFPRYNNPEK
     LLETRCGRCG EWANCFTLCC RAVGFEARYV WDYTDHVWTE VYSPSQQRWL HCDACEDVCD
     KPLLYEIGWG KKLSYVIAFS KDEVVDVTWR YSCKHEEVIA RRTKVKEALL RDTINGLNKQ
     RQLFLSENRR KELLQRIIVE LVEFISPKTP KPGELGGRIS GSVAWRVARG EMGLQRKETL
     FIPCENEKIS KQLHLCYNIV KDRYVRVSNN NQTISGWENG VWKMESIFRK VETDWHMVYL
     ARKEGSSFAY ISWKFECGSV GLKVDSISIR TSSQTFQTGT VEWKLRSDTA QVELTGDNSL
     HSYADFSGAT EVILEAELSR GDGDVAWQHT QLFRQSLNDH EENCLEIIIK FSDL
//
